An Older Voluntary FDA Cancidas® (Caspofungin Acetate | Merck) Recall Notice


Not sure how I missed this first time around — via FDA.gov’s October 20, 2010 Enforcement Report (in the recall notices section):

. . . .PRODUCT

Cancidas® (Caspofungin acetate) for Injection, for Intravenous Use, 50 mg, NDC 0006-3822-10. Recall # D-014-2011

CODE

Lot 1553Y exp 6/30/2010

RECALLING FIRM/MANUFACTURER

Recalling Firm: Merck Sharp & Dohme, West Point, PA, by letter June 7, 2010.

Manufacturer: Merck & Company, Inc., West Point, PA. Firm initiated recall is ongoing.

REASON

Lack of Assurance of Sterility (cracked vials).

VOLUME OF PRODUCT IN COMMERCE

482 vials

DISTRIBUTION

CT, IL, MO, NY, TN, MA, OK, OH, FL, MI, PA, KY. . . .

Carry on.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s